Literature DB >> 32574932

MRI of prostatic urethral mucinous urothelial carcinoma: Expanding the differential diagnosis for T2 hyperintense prostatic masses.

Neel Patel1, Bryan R Foster2, Elena K Korngold2, Kyle Jensen2, Kevin R Turner2, Fergus V Coakley2.   

Abstract

We report the case of a 66-year-old previously healthy man presenting with blood and mucus in his urine. Cystoscopy revealed a mass in the prostatic urethra, and endoscopic biopsy showed adenocarcinoma in situ with mucinous features. Endorectal multiparametric prostate MRI demonstrated a 1.9 cm T2 hyperintense mass in the peripheral zone of the left prostatic apex with extension into the urethral lumen. No diffusion restriction or early enhancement was seen in the mass. Radical prostatectomy was performed, and final pathology demonstrated a mucin-producing urothelial adenocarcinoma arising from the prostatic urethra. The peripheral zone T2 hyperintense abnormality correlated with abundant pools of mucin extending into the prostatic stroma and surrounded by neoplastic prostatic glandular cells. We conclude prostatic urethral mucinous urothelial carcinoma should be included in the differential diagnosis for T2 hyperintense prostatic masses.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  MRI; Prostate; Prostate cancer; Prostatic urethral mucinous adenocarcinoma

Mesh:

Year:  2020        PMID: 32574932     DOI: 10.1016/j.clinimag.2020.06.012

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  1 in total

1.  Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma.

Authors:  Kunihisa Nezu; Teppei Okubo; Manabu Shiraiwa; Yoshihiro Nozawa; Atsushi Kyan
Journal:  IJU Case Rep       Date:  2020-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.